Improving Quality of Life for Veterans With Stroke and Psychological Distress
2 other identifiers
interventional
38
1 country
1
Brief Summary
The study will create a treatment to improves mobility, physical activity, engagement in activities with family and friends and overall satisfaction with life for Veterans who have depression and anxiety after having a stroke. The treatment will then be tested to ensure it makes the desired improvements in the Veterans.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable stroke
Started Nov 2019
Typical duration for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 21, 2018
CompletedFirst Posted
Study publicly available on registry
August 24, 2018
CompletedStudy Start
First participant enrolled
November 20, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 21, 2021
CompletedResults Posted
Study results publicly available
July 18, 2024
CompletedJuly 18, 2024
April 1, 2024
1.8 years
August 21, 2018
October 19, 2022
April 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Stroke Specific Quality of Life Scale Change
The Stroke Specific Quality of Life Scale assesses change in energy, language, vision, mobility, fine motor tasks, mood, personality and thinking, social roles, family roles and work productivity. Scores are reported for the energy, language, mobility, personality, mood, family roles, thinking, and social roles. The score range for each item 1= strongly disagree to 5=strongly agree with a higher score indicating greater disability and worst outcomes. A total score range is 14-70.
Absolute values at 12 weeks post-treatment are being reported
Secondary Outcomes (4)
Physical Activity and Disability Survey Change
The absolute values at 12 weeks post-treatment are being reported
Community Integration Questionnaire Change
The absolute values at 12 weeks post-treatment are being reported
Patient Health Questionnaire-8 Item Change
The absolute values at 12 weeks post-treatment are being reported
General Anxiety Disorder-7 Change
The absolute values at 12 weeks post-treatment are being reported
Study Arms (2)
I'm Whole
EXPERIMENTALThis arm will receive 6 behavioral health treatment sessions that focus on stroke self-management, psychological distress and social re-integration. Treatments will occur weekly. They will also receive 3 assessments at 0, 6, and 12 weeks.
Education + usual care
ACTIVE COMPARATORThis arm will only receive the standard usual care for stroke self-management provided by the Michael E. Debakey VA Medical facility and will receive 6 brief health education calls unrelated to stroke or psychological distress.
Interventions
I'm whole will provide 6 behavioral health treatment sessions that focus on stroke self-management, psychological distress and social re-integration.
Will receive the standard usual care for stroke self-management provided by the Michael E. Debakey VA Medical facility and will receive 6 brief health education calls unrelated to stroke or psychological distress.
Eligibility Criteria
You may qualify if:
- a documented history of stroke and/or transient ischemic attack within the last 30 days
- a modified Rankin score of \> 3)
- regular access to a computer or tablet with internet and a camera
- ability to give appropriate informed consent
- score \> 5 on a measure of depression (Patient Health Questionnaire \[PHQ-8\]) and/or \>17 on a measure of anxiety (Generalized Anxiety Disorder-7 \[GAD-7\]) assessments
- ability to ambulate with or without assistance of a cane or walker
You may not qualify if:
- cognitive impairment, as evidenced by a score of \>3 on a brief cognitive screener
- documented diagnosis of psychotic disorder or schizophrenia
- documented severe depression, anxiety (based on PHQ-8 or GAD-7 score of \> 20), or hospitalization for psychiatric illness within the past 30 days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Michael E. DeBakey VA Medical Center, Houston, TX
Houston, Texas, 77030, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
The small sample size is a limitation.
Results Point of Contact
- Title
- Dr. Gina Evans
- Organization
- Michael E. Debakey VA Medical Center
Study Officials
- PRINCIPAL INVESTIGATOR
Gina L. Evans, PhD
Michael E. DeBakey VA Medical Center, Houston, TX
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- No other parties will be masked
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 21, 2018
First Posted
August 24, 2018
Study Start
November 20, 2019
Primary Completion
August 31, 2021
Study Completion
December 21, 2021
Last Updated
July 18, 2024
Results First Posted
July 18, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share